Frederique Menzaghi's most recent trade in Tvardi Therapeutics Inc. was a trade of 13,500 Common Stock done . Disclosure was reported to the exchange on Feb. 1, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tvardi Therapeutics Inc | Frederique Menzaghi | CHIEF SCIENTIFIC OFF,SVP-R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 13,500 | 167,247 (0%) | 0% | 0 | Common Stock | |
| Tvardi Therapeutics Inc | Frederique Menzaghi | Chief Scientific Off,SVP-R&D | Sale of securities on an exchange or to another person at price $ 3.51 per share. | 23 Jun 2023 | 2,993 | 153,747 (0%) | 0% | 3.5 | 10,505 | Common Stock |
| Tvardi Therapeutics Inc | Frederique Menzaghi | Chief Scientific Off,SVP-R&D | Sale of securities on an exchange or to another person at price $ 4.91 per share. | 04 Apr 2023 | 2,733 | 156,740 (0%) | 0% | 4.9 | 13,419 | Common Stock |
| Tvardi Therapeutics Inc | Frederique Menzaghi | Chief Scientific Off,SVP-R&D | Sale of securities on an exchange or to another person at price $ 9.71 per share. | 03 Mar 2023 | 6,802 | 159,473 (0%) | 0% | 9.7 | 66,047 | Common Stock |
| Tvardi Therapeutics Inc | Frederique Menzaghi | Chief Scientific Off,SVP-R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 81,000 | 81,000 | - | - | Stock Option (Right to Buy) | |
| Tvardi Therapeutics Inc | Frederique Menzaghi | Chief Scientific Off,SVP-R&D | Sale of securities on an exchange or to another person at price $ 11.27 per share. | 21 Dec 2022 | 3,506 | 166,275 (0%) | 0% | 11.3 | 39,513 | Common Stock |
| Tvardi Therapeutics Inc | Frederique Menzaghi | Chief Scientific Off,SVP-R&D | Sale of securities on an exchange or to another person at price $ 11.91 per share. | 01 Apr 2022 | 1,784 | 169,781 (0%) | 0% | 11.9 | 21,247 | Common Stock |
| Tvardi Therapeutics Inc | Frederique Menzaghi | Chief Scientific Off,SVP-R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 40,000 | 40,000 | - | - | Employee Stock Option (Right to Buy) | |
| Tvardi Therapeutics Inc | Frederique Menzaghi | Chief Scientific Off,SVP-R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 20,000 | 173,679 (0%) | 0% | 0 | Common Stock | |
| Tvardi Therapeutics Inc | Frederique Menzaghi | Chief Scientific Off,SVP-R&D | Sale of securities on an exchange or to another person at price $ 10.29 per share. | 25 Feb 2022 | 2,114 | 171,565 (0%) | 0% | 10.3 | 21,753 | Common Stock |
| Tvardi Therapeutics Inc | Frederique Menzaghi | Chief Scientific Off,SVP-R&D | Sale of securities on an exchange or to another person at price $ 14.20 per share. | 30 Aug 2021 | 3,847 | 141,072 (0%) | 0% | 14.2 | 54,627 | Common Stock |
| Tvardi Therapeutics Inc | Frederique Menzaghi | Chief Scientific Off,SVP-R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Aug 2021 | 9,600 | 144,919 (0%) | 0% | 0 | Common Stock | |
| Tvardi Therapeutics Inc | Frederique Menzaghi | Chief Scientific Off,SVP-R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2021 | 32,000 | 32,000 | - | - | Employee Stock Option (Right to Buy) | |
| Tvardi Therapeutics Inc | Frederique Menzaghi | Chief Scientific Off,SVP-R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2021 | 16,000 | 135,319 (0%) | 0% | 0 | Common Stock | |
| Tvardi Therapeutics Inc | Frederique Menzaghi | Chief Scientific Off,SVP-R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 10,000 | 122,677 (0%) | 0% | 0 | Common Stock | |
| Tvardi Therapeutics Inc | Frederique Menzaghi | Chief Scientific Off,SVP-R&D | Sale of securities on an exchange or to another person at price $ 17.98 per share. | 04 Mar 2021 | 3,358 | 119,319 (0%) | 0% | 18.0 | 60,377 | Common Stock |
| Tvardi Therapeutics Inc | Frederique Menzaghi | Chief Scientific Off,SVP-R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 8,000 | 117,680 (0%) | 0% | 0 | Common Stock | |
| Tvardi Therapeutics Inc | Frederique Menzaghi | Chief Scientific Off,SVP-R&D | Sale of securities on an exchange or to another person at price $ 19.33 per share. | 23 Feb 2021 | 5,003 | 112,677 (0%) | 0% | 19.3 | 96,708 | Common Stock |